Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.6 USD | +2.36% | +21.80% | -3.75% |
May. 02 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
Apr. 30 | Top Midday Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.75% | 3.72M | |
+3.93% | 111B | |
+11.38% | 105B | |
-12.84% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.29% | 16.96B | |
+2.41% | 13.7B | |
+35.95% | 12.45B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Cyclacel Pharmaceuticals, Inc. Announces Demise of David U’Prichard, Chairman of the Board of Directors